ARR is really a function of what the total years revenue would be if the customer was billed for the full 12 months. Revenue always trails ARR, but the time lag is probably a function of not 'turning on' deployed systems they have won. The real challenge as you note is that with a ~50% GM, current $8m ARR growth (with a time lag to revenue), is their cash position. Their operating expenses increased in the last half (by about $1.2m), and with a ~$4m cash burn each half ($8m a year and likely increasing), the $11.9m in cash will run out in around 12 months without meaningful revenue growth. This means they will likely need to raise within 9 months from now. Raising money in this environment to fund operating expenses will be tough unless there is a non organic growth opportunity ahead....Clearly burying a raise in another 'growth' story on product wont be possible.
- Forums
- ASX - By Stock
- EVS
- Ann: Investor briefing notification - Q3 Sales Update
EVS
envirosuite limited
Add to My Watchlist
2.50%
!
8.2¢

Ann: Investor briefing notification - Q3 Sales Update, page-13
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.2¢ |
Change
0.002(2.50%) |
Mkt cap ! $118.8M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $196.0K | 2.425M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 179727 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.3¢ | 209692 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 179727 | 0.082 |
1 | 1790783 | 0.081 |
4 | 677759 | 0.080 |
3 | 1668871 | 0.079 |
3 | 698163 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.083 | 209692 | 2 |
0.084 | 260627 | 6 |
0.085 | 874469 | 10 |
0.086 | 2030000 | 2 |
0.087 | 694750 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EVS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online